SCHEMBL4089140

SCHEMBL4089140

CC(C)Oc1ccc(-n2c(C(=O)O)cc3c(Oc4cccc(C(F)(F)F)c4)nc(Oc4cccc(C(F)(F)F)c4)cc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 16/20 0.46
PTGES O14684 2/20 0.46
PPARA Q07869 6/20 0.46
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4102319 0.89 KDM4E (0.46) PPARGPPARAMAPT
SCHEMBL4095174 0.83 PTGES (0.51) PPARGPTGESPPARAMAPT
SCHEMBL4921606 0.83 PTGES (0.61) PPARGPTGESPPARA
SCHEMBL4228522 0.74 PTGES (0.59) PTGES
SCHEMBL4923306 0.74 PTGES (0.52) PTGES
SCHEMBL4096749 0.73 PTGES (0.47) PPARGPTGESPPARAMAPT
SCHEMBL4097225 0.73 KDM4E (0.47) PPARGPTGESPPARAMAPT
SCHEMBL4097221 0.73 PTGES (0.55) PPARGPTGES
Water SCHEMBL4923346 0.73 PTGES (0.66) PPARGPTGESPPARA
Water SCHEMBL4923358 0.73 PTGES (0.66) PPARGPTGESPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048285-A1 Pyrrolopyridines Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048285-A1 Pyrrolopyridines Useful in the Treatment of Inflammation PYCR1, ARG2, ARG1 PPARG 1316/4885PTGES 47/4885PPARA 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.